Safety and efficacy of a generic fixed-dose combination of stavudine, lamivudine and nevirapine antiretroviral therapy between HIV-infected patients with baseline CD4 <50 versus CD4 ≥ 50 cells/mm<sup>3</sup>

Safety and efficacy of a generic fixed-dose combination of stavudine, lamivudine and nevirapine antiretroviral therapy between HIV-infected patients with baseline CD4 <50 versus CD4 ≥ 50 cells/mm<sup>3</sup>

<p>Abstract</p> <p>Background</p> <p>Antiretroviral therapy (ART) with a generic fixed-dose combination (FDC) of stavudine (d4T)/lamivudine (3TC)/nevirapine (NVP) is widely used in developing countries. The clinical data of this FDC among very advanced HIV-infected pati...

Full description

Bibliographic Details
Main Authors: Likanonsakul Sirirat, Chimsuntorn Sukanya, Manosuthi Weerawat, Sungkanuparph Somnuek
Format: Article
Language:English
Published: BMC 2007-03-01
Series:AIDS Research and Therapy
Online Access:http://www.aidsrestherapy.com/content/4/1/6

Internet

http://www.aidsrestherapy.com/content/4/1/6

Similar Items